earnings
XF
NASDAQ · XFOR
X4 Pharmaceuticals, Inc.
Healthcare · Biotechnology
$2.77
Down-$0.13 (-4.48%)
Updated Oct 7, 2026, 3:18 AM
SID Score
2.9/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 44.21M
- P/E ratio
- -0.28
- Dividend yield
- 0.00%
- 52-week range
- $2.73 – $4.83
- Volume
- 642.47K
- Avg. volume
- 894.59K
Price performance · XFOR
XFOR price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 6, 2026
XFOR closed at $2.77 after 21 trading sessions, down 20.97% for the selected period.
- Last close
- $2.77
- Period change
- -20.97%
- Period low
- $2.77
- Period high
- $3.62
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 6, 2026 | $2.90 | $2.90 | $2.70 | $2.77 | 642.47K |
| Oct 5, 2026 | $2.88 | $2.935 | $2.73 | $2.90 | 698.1K |
| Oct 2, 2026 | $2.86 | $2.86 | $2.745 | $2.83 | 911.4K |
| Oct 1, 2026 | $2.89 | $2.95 | $2.82 | $2.83 | 501.49K |
| Sep 30, 2026 | $2.93 | $2.935 | $2.845 | $2.90 | 1.76M |
| Sep 29, 2026 | $3.01 | $3.055 | $2.895 | $2.90 | 1.71M |
| Sep 28, 2026 | $2.996 | $3.04 | $2.81 | $3.015 | 838.4K |
| Sep 25, 2026 | $2.98 | $3.0834 | $2.965 | $3.01 | 1.86M |
| Sep 24, 2026 | $3.10 | $3.10 | $2.955 | $3.00 | 973.68K |
| Sep 23, 2026 | $3.41 | $3.42 | $3.035 | $3.11 | 2.31M |
| Sep 22, 2026 | $3.52 | $3.57 | $3.40 | $3.43 | 923.76K |
| Sep 21, 2026 | $3.58 | $3.58 | $3.455 | $3.495 | 444.36K |
| Sep 18, 2026 | $3.48 | $3.635 | $3.48 | $3.58 | 1.54M |
| Sep 17, 2026 | $3.56 | $3.585 | $3.41 | $3.50 | 635.05K |
| Sep 16, 2026 | $3.63 | $3.65 | $3.355 | $3.51 | 973.34K |
| Sep 15, 2026 | $3.60 | $3.64 | $3.31 | $3.62 | 2.08M |
| Sep 14, 2026 | $3.51 | $3.711 | $3.47 | $3.62 | 1.02M |
| Sep 11, 2026 | $3.44 | $3.55 | $3.24 | $3.50 | 1.25M |
| Sep 10, 2026 | $3.60 | $3.675 | $3.31 | $3.40 | 2.57M |
| Sep 9, 2026 | $3.50 | $3.67 | $3.45 | $3.60 | 1.4M |
| Sep 8, 2026 | $4.00 | $4.1254 | $3.19 | $3.505 | 2.32M |
Latest XFOR news
The latest Smart Investors Daily articles mentioning XFOR.
Stock researchCompany · Financials
Company
Market Activity
Research & News
Loading stock research…

